TI
REGN icon

Turner Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Turner Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,290
Closed -$3.41M – 248
2015
Q4 		$3.41M Sell
6,290
-4,820
-43% -$2.61M 0.71% 51
2015
Q3 		$5.17M Buy
11,110
+2,950
+36% +$1.58M 1.05% 25
2015
Q2 		$4.16M Sell
8,160
-1,790
-18% -$874K 0.76% 38
2015
Q1 		$4.49M Sell
9,950
-4,268
-30% -$1.81M 0.81% 30
2014
Q4 		$5.83M Sell
14,218
-2,194
-13% -$863K 0.69% 25
2014
Q3 		$5.92M Sell
16,412
-3,106
-16% -$1.04M 0.36% 74
2014
Q2 		$5.51M Sell
19,518
-12,012
-38% -$3.56M 0.24% 119
2014
Q1 		$9.47M Sell
31,530
-52,099
-62% -$16.1M 0.25% 144
2013
Q4 		$23M Sell
83,629
-24,865
-23% -$7.15M 0.41% 75
2013
Q3 		$33.9M Sell
108,494
-29,115
-21% -$7.66M 0.56% 43
2013
Q2 		$30.9M Buy
+137,609
New +$32M 0.42% 70

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Turner Investments's REGN Position: Q1 2016 in Review

Turner Investments sold out of Regeneron Pharmaceuticals (REGN) in Q1 2016, closing a stake of 6,290 shares — an estimated $3.41M sold.

Turner Investments first reported a position in REGN in Q2 2013 and held it in 11 quarters. The position peaked at $33.9M in Q3 2013. 550 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

  • Turner Investments reported no remaining Regeneron Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Turner Investments sold 6,290 Regeneron Pharmaceuticals shares in Q1 2016, an estimated $3.41M.
  • Turner Investments first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Turner Investments's Regeneron Pharmaceuticals position peaked at $33.9M in Q3 2013.
  • 550 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.